Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04942535 · ClinicalTrials.gov registry record · NA
STEP Together: An Effectiveness-Implementation Study of Social Incentives and Physical Activity
A NA study of Physical Activity, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 779
- Enrollment target
- 1
- Study location
NCT04942535: Completed NA study of Physical Activity, sponsored by Abramson Cancer Center at Penn Medicine.
NCT04942535 is a NA study of Physical Activity that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 779 participants, above the 352-participant average among 131 other Physical Activity trials with a reported enrollment target (121% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04942535, a NA study of Physical Activity, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 779 participants
- Enrollment target
- 1
- Study location
Study Summary
Higher levels of physical activity have been demonstrated to improve health across a wide range of contexts and reduce cognitive decline as adults become older, but more than half of all adults in the United States do not meet their physical activity goals. One type of physical activity that is broadly applicable to people of all ages is walking. This study will use a Hybrid Type 1 effectiveness-implementation design to adapt and test the effectiveness of two successful social incentive-based interventions, a gamification strategy and financial incentives donated to charity on the participants behalf, to increase physical activity among low-income, mostly minority families in community settings.
Primary Outcome
Change in mean daily steps from baseline to the end of the 12 month intervention period. Steps will be measured using the Fitbit Inspire 2 wearable device.
Conditions Studied
Interventions
- BEHAVIORAL Social Incentive Gamification
- BEHAVIORAL Social Goals through Incentives to Charity
- BEHAVIORAL Daily Performance Feedback
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 779 participants |
| Start Date | 2021-09-21 |
| Est. Completion | 2025-10-11 |
| Phase | NA |
What the finished NCT04942535 record still lists
NCT04942535 is an interventional study that assigns participants to a tested intervention. The registered 779 participants enrollment target is mid-sized for trials with a published cap, above the 352-participant average among 131 other Physical Activity trials with a reported enrollment target (121% higher).
The record links to 1 condition, with Physical Activity appearing as the primary indexed condition, and to 3 interventions - of which Social Incentive Gamification is the first listed.
NCT04942535 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04942535 about?
NCT04942535 is a clinical study titled "STEP Together: An Effectiveness-Implementation Study of Social Incentives and Physical Activity". Higher levels of physical activity have been demonstrated to improve health across a wide range of contexts and reduce cognitive decline as adults become older, but more than half of all adults in the United States do not meet their physical activity goals. One type of physical activity that is broa...
What is the current status of trial NCT04942535?
This trial is currently completed. It is a NA study. The enrollment target is 779 participants. The study started on 2021-09-21. Estimated completion is 2025-10-11.
What conditions does trial NCT04942535 study?
This clinical trial studies the following conditions: Physical Activity.
What interventions are being tested in trial NCT04942535?
The interventions under investigation include: Social Incentive Gamification (BEHAVIORAL), Social Goals through Incentives to Charity (BEHAVIORAL), Daily Performance Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT04942535?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04942535 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04942535's enrollment target sits among peer trials
779 13th of 131 higher than 119 of 131 other Physical Activity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Va Meh Du: A Sports-based Mental Health Promotion Intervention for Karenni Refugees
RECRUITING · NA
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
- NCT05513872 · 780 participants · Phase 1
Overcoming Nicotine Dependence to Enable Quitting
- NCT06310031 · 780 participants · NA
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI